VEGFA and retinopathy of prematurity: Recently, the use of anti-VEGF drugs has revolutionized the treatment of ROP, as these agents have several distinct advantages over conventional standard laser photocoagulation therapy, including a simpler procedure and reduced risks of myopia and peripheral visual field defects2.